T. Tabatabaie et al., Inhibition of the cytokine-mediated inducible nitric oxide synthase expression in rat insulinoma cells by phenyl N-tert-butylnitrone, NITRIC OXID, 4(2), 2000, pp. 157-167
Cytokines and nitric oxide (NO) have been implicated in the pathogenesis of
insulin-dependent diabetes mellitus (IDDM). We have shown that the spin-tr
apping agent phenyl N-tert-butylnitrone (PBN) protects against streptozotoc
in (STZ)-induced IDDM in mice. In order to gain more insights into the mech
anism(s) of the protective action of PBN against IDDM, we have investigated
the effect of this compound on the cytokine-induced NO generation (measure
d as nitrite) in rat insulinoma RIN-SF cells. Our results demonstrate that
PEN cotreatment prevents the generation of nitrite by RIN-5F cells induced
by treatment with tumor necrosis factor-alpha, interleukin 1 beta, and inte
rferon-gamma in a dose-dependent fashion. The generation of NO as a result
of cytokine treatment and the inhibitory effect of PEN were further confirm
ed by electron paramagnetic resonance spectroscopy. Aminoguanidine, a selec
tive inhibitor of inducible nitric oxide synthase (iNOS), abolished the cyt
okine-induced nitrite generation whereas N-nitro-L-arginine, an inhibitor m
ore selective for other NOS isoforms, was significantly less effective. Wes
tern and Northern analyses demonstrated that PEN inhibits the cytokine-medi
ated expression of iNOS at the transcriptional level. Cytokine-induced nitr
ite formation was also inhibited by the two antioxidant agents alpha-lipoic
acid and N-acetylcysteine. These results indicate that PBN protects agains
t IDDM at least in part by prevention of cytokine-induced NO generation by
pancreatic beta-cells. (C) 2000 Academic Press.